RIMEGEPANT SULFATE | N212728 | PFIZER INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Pfizer Inc. et al v. Changzhou Pharmaceutical Factory 3 patentsANDA 219385rimegepant sulfate | D. Del. | 2024-05-23 | Active | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Suitability Petition from Ascent Pharmaceuticals Inc FDA-2025-P-0392 Ascent Pharmaceuticals Inc filed this suitability petition under Section 505(j)(2)(C) requesting FDA approval to pursue an abbreviated new drug application for rimegepant oral dissolving film 75 mg, changing the dosage form from the reference-listed drug NURTEC ODT (orally disintegrating tablets 75 | Suitability | 2025-02-05 | Open | Ascent Pharmaceuticals Inc |
Source: Regulations.gov. FDA citizen petitions matched by application number.